Related Experiment Video
Updated: Mar 15, 2026
04:06
Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
Published on: September 13, 2024
3.7K
Occipital Nerve Stimulation for Refractory Occipital Neuralgia: A Multicenter, Randomized, Controlled Trial [StimO
Stéphanie Ravaillault1,2, Homaon Alipour3, François Leger4
1Department of Neurosurgery, UIC22, University Hospital, F-44000 Nantes, France.
Journal of Clinical Medicine
|March 14, 2026
Summary
Occipital nerve stimulation (ONS) significantly reduced pain and medication use in patients with refractory occipital neuralgia. This treatment also improved quality of life after six months compared to optimized medical management.
Area of Science:
- Neurology
- Pain Management
- Neurosurgery
Background:
- Occipital neuralgia (ON) is a disabling primary headache disorder.
- Its pathophysiology involves nerve sensitization and central pain pathways.
- Refractory ON poses a significant challenge in clinical practice.
Purpose of the Study:
- To evaluate the effectiveness of occipital nerve stimulation (ONS) for refractory occipital neuralgia.
- To compare ONS with optimized medical management (OMM).
Main Methods:
- Prospective, randomized, controlled, parallel-group study (StimO trial).
- Two groups: ONS and OMM.
- Six-month follow-up period.
Main Results:
- ONS group showed significantly greater pain reduction at 6 months (p=0.04).
- Improved quality of life (EQ5D) in the ONS group at 1 month (p=0.01).
- Reduced medication use (MQS) in the ONS group at 1, 3, and 6 months (p=0.03).
Conclusions:
- Occipital nerve stimulation is a safe and effective therapy for refractory occipital neuralgia.
- ONS decreases pain, reduces medication dependence, and enhances quality of life.
- ONS did not significantly affect anxiety or depression.
